Brisbane, CA, United States of America

Didier Rouy

This inventor holds 1 USPTO granted patent. Top assignee: Sangamo Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Didier Rouy. Retrieved from https://idiyas.com/inventor/didier-rouy-lqtuj1h8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Didier Rouy

Introduction

Didier Rouy is a notable inventor based in Brisbane, California. He has made significant contributions to the field of biotechnology, particularly in the area of clinical parameters related to Factor VIII. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Didier Rouy holds a patent titled "Improved Clinical Parameters by Expression of Factor VIII." This patent reflects his commitment to advancing medical science and improving patient outcomes through innovative solutions. He has 1 patent to his name, highlighting his focused contributions to the field.

Career Highlights

Rouy is currently employed at Sangamo Therapeutics, Inc., a company known for its pioneering work in gene therapy and genomic medicine. His role at Sangamo Therapeutics allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Didier Rouy has worked alongside talented colleagues such as Brigit E. Riley and Edward R. Conner. These collaborations enhance the innovative environment at Sangamo Therapeutics and foster the development of new therapeutic approaches.

Conclusion

Didier Rouy exemplifies the spirit of innovation in biotechnology through his patent and work at Sangamo Therapeutics. His contributions are vital to advancing medical science and improving clinical outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…